$2.55
N/A
Last update: Oct 23, 7:55 PM
Artelo Biosciences Inc (ARTL) Stock Price, Quote, News & History
ARTLNASDAQ
AIM ImmunoTech (AMEX: AIM) sees bullish momentum after final patent approval in Japan for its Ampligen-based oncology treatments.
You can purchase shares of Artelo Biosciences (NASDAQ:ARTL) through any online brokerage.
Other companies in Artelo Biosciences’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Artelo Biosciences has a consensus price target of $891.00.
The stock price for Artelo Biosciences (NASDAQ: ARTL) is $2.5 last updated October 23, 2026 at 7:55 PM EDT.
There are no upcoming dividends for Artelo Biosciences.
Artelo Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Artelo Biosciences.
Artelo Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors &...
